XYXiaolu Yang

Xiaolu Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaolu Yang has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RNA programmable cell targeting and manipulation with CellREADR

    by Xiaolu Yang, Kehali Woldemichael, John Hover, Shengli Zhao, Xiao Guo, Yongjun Qian, Jesse Gillis, Z. Josh Huang

    Methods that provide specific, easy, and scalable experimental access to animal cell types and cell states will have broad applications in biology and medicine. CellREADR - Cell access through RNA sensing by Endogenous ADAR (adenosine deaminase acting on RNA), is a programmable RNA sensor-actuator technology that couples the detection of a cell-defining RNA to the translation of an effector protein to monitor and manipulate the cell. The CellREADR RNA device consists of a 5’ sensor region complementary to a cellular RNA and a 3’ payload coding region; payload translation is gated by the removal of a STOP codon in the sensor region upon base pairing with the cognate cellular RNA through an ADAR-mediated A- to-I editing mechanism ubiquitous to metazoan cells. CellREADR thus highlights the potential for RNA-based monitoring and manipulation of animal cells in ways that are simple, versatile, and generalizable across tissues and species. Here, we describe a detailed protocol for implementing CellREADR experiments in cell cultures and in animals. The procedure includes sensor and payload design, cloning, validation and characterization in mammalian cell cultures. The in vivo animal protocol focuses on AAV-based delivery of CellREADR using brain tissue as examples. We describe current best practices, various experimental controls and trouble-shooting steps. Beginning from sensor design, the validation of RNA sensor-actuators in cell cultures can be completed in 2-3 weeks. The construction of AAV vectors and their in vivo validation and characterization will take additional 6-8 weeks.

  • Open Access

    Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma

    by Yige Wu, Siqi Chen, Xiaolu Yang, Kazuhito Sato, Preet Lal, Yuefan Wang, Andrew T. Shinkle, Michael C. Wendl, Tina M. Primeau, Yanyan Zhao, et al.

    Current treatment approaches for renal cell carcinoma (RCC) face challenges in achieving durable tumor responses due to tumor heterogeneity and drug resistance. Combination therapies that leverage tumor molecular profiles could offer an avenue for enhancing treatment efficacy and addressing the limitations of current therapies. To identify effective strategies for treating RCC, we selected ten drugs guided by tumor biology to test in six RCC patient-derived xenograft (PDX) models. The multitargeted tyrosine kinase inhibitor (TKI) cabozantinib and mTORC1/2 inhibitor sapanisertib emerged as the most effective drugs, particularly when combined. The combination demonstrated favorable tolerability and inhibited tumor growth or induced tumor regression in all models, including two from patients who experienced treatment failure with FDA-approved TKI and immunotherapy combinations. In cabozantinib-treated samples, imaging analysis revealed a significant reduction in vascular density, and single-nucleus RNA sequencing (snRNA-seq) analysis indicated a decreased proportion of endothelial cells in the tumors. SnRNA-seq data further identified a tumor subpopulation enriched with cell-cycle activity that exhibited heightened sensitivity to the cabozantinib and sapanisertib combination. Conversely, activation of the epithelial–mesenchymal transition pathway, detected at the protein level, was associated with drug resistance in residual tumors following combination treatment. The combination effectively restrained ERK phosphorylation and reduced expression of ERK downstream transcription factors and their target genes implicated in cell-cycle control and apoptosis. This study highlights the potential of the cabozantinib plus sapanisertib combination as a promising treatment approach for patients with RCC, particularly those whose tumors progressed on immune checkpoint inhibitors and other TKIs.Significance: The molecular-guided therapeutic strategy of combining cabozantinib and sapanisertib restrains ERK activity to effectively suppress growth of renal cell carcinomas, including those unresponsive to immune checkpoint inhibitors.


  • Open Access

    Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma

    by Yige Wu, Nadezhda V. Terekhanova, Wagma Caravan, Nataly Naser Al Deen, Preet Lal, Siqi Chen, Chia-Kuei Mo, Song Cao, Yize Li, Alla Karpova, et al.


  • Open Access

    Nitric oxide-mediated S-nitrosylation of IAA17 protein in intrinsically disordered region represses auxin signaling

    by Hongwei Jing, Xiaolu Yang, Ryan J. Emenecker, Jian Feng, Jian Zhang, Marcelo Rodrigues Alves de Figueiredo, Patarasuda Chaisupa, R. Clay Wright, Alex S. Holehouse, Lucia C. Strader, et al.


  • Open Access

    Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma

    by Yige Wu, Nadezhda V. Terekhanova, Wagma Caravan, Nataly Naser Al Deen, Preet Lal, Siqi Chen, Chia-Kuei Mo, Song Cao, Yize Li, Alla Karpova, et al.

    Identifying tumor-cell-specific markers and elucidating their epigenetic regulation and spatial heterogeneity provides mechanistic insights into cancer etiology. Here, we perform snRNA-seq and snATAC-seq in 34 and 28 human clear cell renal cell carcinoma (ccRCC) specimens, respectively, with matched bulk proteogenomics data. By identifying 20 tumor-specific markers through a multi-omics tiered approach, we reveal an association between higher ceruloplasmin (CP) expression and reduced survival.CPknockdown, combined with spatial transcriptomics, suggests a role for CP in regulating hyalinized stroma and tumor-stroma interactions in ccRCC. Intratumoral heterogeneity analysis portrays tumor cell-intrinsic inflammation and epithelial-mesenchymal transition (EMT) as two distinguishing features of tumor subpopulations. Finally,BAP1mutations are associated with widespread reduction of chromatin accessibility, whilePBRM1 mutations generally increase accessibility, with the former affecting five times more accessible peaks than the latter. These integrated analyses reveal the cellular architecture of ccRCC, providing insights into key markers and pathways in ccRCC tumorigenesis.


  • Open Access

    S -nitrosylation of Aux/IAA protein represses auxin signaling

    by Hongwei Jing, Xiaolu Yang, Jian Feng, Jian Zhang, Lucia C. Strader, Jianru Zuo

    Auxin plays crucial roles in nearly every aspect of plant growth and development. Auxin signaling activation is mediated through degradation of Auxin/INDOLE-3-ACETIC ACID (Aux/IAA) family. Nitric oxide (NO) regulates diverse cellular bioactivities through S -nitrosylation of target protein at specific cysteine residues. NO-auxin interplay has an important role in regulation plant growth. However, little is known about the molecular mechanism of how NO effects Aux/IAA proteins stability. Here we show that NO negatively regulates the IAA17 protein stability to repress auxin signaling. We found that NO directly inhibits IAA17 protein degradation. S -nitrosylation of IAA17 at Cys-70 represses the TIR-IAA17 co-receptor interaction to attenuate auxin responsiveness. Our data suggest a model in which S -nitrosylation of IAA17 at Cys-70 negatively regulates auxin signaling to effect plant development, providing a mechanism for redox-phytohormones networks.


  • Programmable RNA sensing for cell monitoring and manipulation

    by Yongjun Qian, Jiayun Li, Shengli Zhao, Elizabeth A. Matthews, Michael Adoff, Weixin Zhong, Xu An, Michele Yeo, Christine Park, Xiaolu Yang, et al.

    RNA is a central and universal mediator of genetic information underlying the diversity of cell types and cell states, which together shape tissue organization and organismal function across species and lifespans. Despite numerous advances in RNA sequencing technologies and the massive accumulation of transcriptome datasets across the life sciences1,2, the dearth of technologies that use RNAs to observe and manipulate cell types remains a bottleneck in biology and medicine. Here we describe CellREADR (Cell access through RNA sensing by Endogenous ADAR), a programmable RNA-sensing technology that leverages RNA editing mediated by ADAR to couple the detection of cell-defining RNAs with the translation of effector proteins. Viral delivery of CellREADR conferred specific cell-type access in mouse and rat brains and in ex vivo human brain tissues. Furthermore, CellREADR enabled the recording and control of specific types of neurons in behaving mice. CellREADR thus highlights the potential for RNA-based monitoring and editing of animal cells in ways that are specific, versatile, simple and generalizable across organ systems and species, with wide applications in biology, biotechnology and programmable RNA medicine.


  • Open Access

    Chromatin accessibility shapes tumor architecture and microenvironment in clear cell renal cell carcinoma

    by Yige Wu, Nadezhda Terekhanova, Wagma Caravan, Alla Karpova, Song Cao, Siqi Chen, Houxiang Zhu, Preet Lal, Mamatha Serasanambati, Xiaolu Yang, et al.

    The molecular landscape of clear cell renal cell carcinoma (ccRCC) has been annotated by a number of large-scale sequencing studies, complemented by recent proteomics efforts. However, these bulk analyses are limited by the diverse cell populations that compose these tumors. Here, we obtained single-nucleus RNA-seq (snRNA-seq) and ATAC-seq (snATAC-seq) data from 31 and 13 samples from ccRCC patients, respectively, with matching bulk proteogenomics data collected through the National Cancer Institute Clinical Proteomic Tumor Analysis Consortium (CPTAC). We found an average of 4 distinct populations of tumor cells with substantial transcriptional differences per sample and 7.5% of clusters with epithelial-to-mesenchymal transition (EMT) features, characterized by high expression of known mesenchymal genes, and Wnt pathway genes and enriched TWIST and AP-1 complex (JUN, ATF2) motifs. We also observed substantial tumor genomic heterogeneity, including cluster-specific chromosome 3p loss and 5q gain from the same patient, suggesting both events can drive ccRCC, possibly through tumor cell interactions. We identified growth factor-receptor interactions between IGF1 (macrophages) and IGF1R (tumor cells), HBEGF (macrophages) and EGFR (tumor cells), in addition to the well-known interaction between VEGFA (tumor cells) and FLT1 (endothelial cells). Using paired snATAC-seq and snRNA-seq, we found ccRCC cells were most similar to proximal tubule cells among the six nephron epithelial cell types identified. We also identified previously unknown tumor cell-specific transcription factor (TF) motifs, including those for NFIC, RORC, and RBPJ, regulating genes involved in glycolysis (PFKP), and others potentially in collaboration with HIF1A. Finally, tumors harboring genetic alterations in chromatin remodeling genes (BAP1/PBRM1) showed distinct genome-wide and fine-scale chromatin accessibility profiles compared to other tumors, with enriched motifs for the nuclear factor-κB TFs. In summary, we find that various differential transcriptional network activities are likely key drivers in ccRCC pathogenesis and progression.

  • Open Access

    Genetic variations in ARE1 mediate grain yield by modulating nitrogen utilization in rice

    by Qing Wang, Jinqiang Nian, Xianzhi Xie, Hong Yu, Jian Zhang, Jiaoteng Bai, Guojun Dong, Jiang Hu, Bo Bai, Lichao Chen, et al.

    In crops, nitrogen directly determines productivity and biomass. However, the improvement of nitrogen utilization efficiency (NUE) is still a major challenge in modern agriculture. Here, we report the characterization of are1, a genetic suppressor of a rice fd-gogat mutant defective in nitrogen assimilation. ARE1 is a highly conserved gene, encoding a chloroplast-localized protein. Loss-of-function mutations in ARE1 cause delayed senescence and result in 10–20% grain yield increases, hence enhance NUE under nitrogen-limiting conditions. Analysis of a panel of 2155 rice varieties reveals that 18% indica and 48% aus accessions carry small insertions in the ARE1 promoter, which result in a reduction in ARE1 expression and an increase in grain yield under nitrogen-limiting conditions. We propose that ARE1 is a key mediator of NUE and represents a promising target for breeding high-yield cultivars under nitrogen-limiting condition.


  • Rice Ferredoxin-Dependent Glutamate Synthase Regulates Nitrogen–Carbon Metabolomes and Is Genetically Differentiated between japonica and indica Subspecies

    by Xiaolu Yang, Jinqiang Nian, Qingjun Xie, Jian Feng, Fengxia Zhang, Hongwei Jing, Jian Zhang, Guojun Dong, Yan Liang, Juli Peng, et al.